Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.
about
Predictive value of epigenetic alterations in head and neck squamous cell carcinomaDecreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.Development of a Biomimetic Chondroitin Sulfate-modified Hydrogel to Enhance the Metastasis of Tumor Cells.Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.The regulatory mechanisms of NG2/CSPG4 expression.Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.
P2860
Q27690755-9CB04CC9-AD8B-4CD4-A328-764AF25A4761Q35238408-E038A0DC-99F6-4CB7-BD8B-DE4F11112321Q35599740-0929FDD4-B541-49C6-B84B-99FC66FB1435Q37105043-C36E6598-E170-43F0-8EC4-BA88BA439E70Q38550541-6720985B-3017-484F-9EF4-BFDFA964A070Q39325532-6D8FB45B-7A80-4FFC-AB72-72BB8AA3FD0AQ40517870-DB47F661-B159-47AD-B26C-0A4E27503BFDQ47555734-26FEF708-DFA1-43CA-A670-E94267F45BC8Q50918966-7776ADB7-3B89-4CAA-AEE3-DC19D42FA33B
P2860
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Reduced promoter methylation a ...... es survival of HNSCC patients.
@en
Reduced promoter methylation a ...... es survival of HNSCC patients.
@nl
type
label
Reduced promoter methylation a ...... es survival of HNSCC patients.
@en
Reduced promoter methylation a ...... es survival of HNSCC patients.
@nl
prefLabel
Reduced promoter methylation a ...... es survival of HNSCC patients.
@en
Reduced promoter methylation a ...... es survival of HNSCC patients.
@nl
P2093
P2860
P356
P1476
Reduced promoter methylation a ...... es survival of HNSCC patients.
@en
P2093
Andreas Mock
Carolin Mogler
Christoph Plass
Esther Herpel
Florian Osswald
Gerhard Dyckhoff
Jittiporn Chaisaingmongkol
Odilia Popanda
Peter Plinkert
Peter Schmezer
P2860
P304
P356
10.1002/IJC.28906
P577
2014-04-26T00:00:00Z